AUSTIN, Texas (AP) ¿ Luminex Corp. on Friday said that the U.S. Food and Drug Administration has given approval for the company's new cystic fibrosis test.

The test detects for 39 gene mutations that cause cystic fibrosis, the company said. It can be used for diagnosis or to screen potential parents to determine if they are carriers for the disease-causing gene mutations.

Shares of Luminex rose 76 cents to $15.62 in afternoon trading Friday.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Food & Drink

The Demise of the Great American Supermarket (Watch!)

The Demise of the Great American Supermarket (Watch!)

The Great American Supermarket No Longer Reigns Supreme

The Great American Supermarket No Longer Reigns Supreme

Kohl's May Blame Winter Weather for First-Quarter Earnings Slip

Kohl's May Blame Winter Weather for First-Quarter Earnings Slip

Watch McDonald's Workers Storm HQ to Protest Fast-Food Giant's Pay

Watch McDonald's Workers Storm HQ to Protest Fast-Food Giant's Pay

Campbell Soup Slips as CEO Unexpectedly Retires

Campbell Soup Slips as CEO Unexpectedly Retires